TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PAM-13 scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthy eating improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diabetes self-efficacy improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: gains in body image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: alcohol consumption in standard drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postbiopsy hyponatraemia (sodium <135 mmol/L)
Endpoint domain: Adverse events/effects
Primary endpoint: Prediction accuracy of cause of death
Endpoint domain: Mortality/survival
Primary endpoint: Increase in HDL CEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Short Inventory of Problems-Revised scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kessler-10 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of blood pressure exceeding 20% and 30% of basal blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Norepinephrine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VF subscale scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ovarian reserve improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Concern About AD scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Corneal endothelial cell density (ECD) loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clearance rates of facial AK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic drug consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: DAS28‐CRP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDHAQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TBUT and CFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telomere length (TL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telomerase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported cesarean rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: mean hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T/iCa levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson Disease Questionnaire‐39 items
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 1-repetition maximum bench press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of STIs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients reaching PASS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: morphine equivalents (MEQs) consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global quality of life improvement at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Obturator nerve reflex (ONR) cases
Endpoint domain: Adverse events/effects
Primary endpoint: Conversion to conventional TURBT
Endpoint domain: Adverse events/effects
Primary endpoint: Engagement in the Vx task
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: composite primary cardiovascular outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of probable dementia
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of incorrect working steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress reduction using cognitive aids
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean average pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident or recurrent major depression
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum pain score at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge gap incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of TriV pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reporting of barriers to screening mammography
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: annualized flare rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood eosinophil count reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: reduction in mean daily dose of OCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in femoral neck and total hip aBMD Z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Changes in trabecular vBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Changes in tibial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Frequency of chronic inguinodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate of SVF-enriched fat grafts
Endpoint domain: Mortality/survival
Primary endpoint: VISIA values of wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VISIA values of texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cremaster relaxation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean D2cc changes (Gy) to OARs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: etiological accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum LDL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduction in cSMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Respiratory Distress Assessment Instrument (mRDAI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of delirium identified by NLP-CAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of delirium identified by NLP-mCAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptomatic urinary tract infection at 2 weeks after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dashboard views
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Broad-spectrum prescribing reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxious and depressed behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: internalizing behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: interpersonal relationship adaptive behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: CSS score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage change in upper airway volumetric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage change in Apnea Hypopnea Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage change in Respiratory Disturbance Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Effectiveness at preventing death from COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Mean injection times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student engagement in nutrition concepts
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Awareness of healthy eating and serve size recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement/maintenance of DRSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in incisor torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hypoglycemic duration
Endpoint domain: Adverse events/effects
Primary endpoint: Median time to loss of ambulation (LOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FVC% change annually
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall recovery quality at day 7 after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Central Macular Thickness (CMT) reduction after aflibercept injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trauma memory distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: proactive interference
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Median NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesics consumption over 24 h postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sustained change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximum and mean pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of pain on work, personal relationships, and sleep and rest
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Five-year actuarial survival probability
Endpoint domain: Mortality/survival
Primary endpoint: Five-year progression-free probability
Endpoint domain: Mortality/survival
Primary endpoint: Serum NfL concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCQ‐Brief scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pTGV prediction model performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of OAB on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean VAS scores for acute pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total abdominal fat increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of MSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response to therapy
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: incidence of early postoperative cognitive decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic accuracy of CPRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-test probability of a positive or negative test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed antibiotic prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Superoxide dismutase (SOD) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median duration of postoperative hypotension (TWA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of uncorrected visual impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local recurrence risk
Endpoint domain: Mortality/survival
Primary endpoint: Intentions to test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: all-cause inpatient readmission or death
Endpoint domain: Mortality/survival
Primary endpoint: any breastfeeding duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Function Index (FSFI) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sex partner satisfaction improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean change in countermovement jump peak power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-m sprint time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach target INR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of enoxaparin consumption per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Risk of RDKF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incident uveitis requiring treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Improvements of ≥15-letter BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in gingival inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hip abduction range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bent knee fall out test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hippocampal sparing metrics (Dmin and Dmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HRV recovery after resistance exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure recovery after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postprandial satiety sensations (3 h-iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of doses transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of unused doses at the end of the trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean percentages of total unmet demand
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Grit
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Tissue/tumor growth
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of HbA1c ≤6.5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholesterol levels (total and LDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective Patient Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to participate in the RCT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone Mineral Density (BMD) in the left hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Z score in the left hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher rates of vegetative state
Endpoint domain: Adverse events/effects
Primary endpoint: lower or upper severe disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for vasopressor medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Assessment of Chronic Illness Therapy-fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Anxiety and Depression Scale-depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospital Anxiety and Depression Scale-anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of all-cause stroke
Endpoint domain: Mortality/survival
Primary endpoint: Rate of total hospitalizations due to cardiac disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: success rate for epidural placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSI score at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of left hippocampal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Childbirth pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of psychological symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IL-1β serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage time of slow‐wave sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embolic stroke occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: compliance behavior of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Endurance in the TTE test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during exercise
Endpoint domain: Adverse events/effects
Primary endpoint: facial satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: prolonged postoperative opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported fear scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vaccine response (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine response (WBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine response (IL-1Ra)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean postural tremor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of total antibodies (IgG and IgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Th1-biased cellular immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time saved in medication reconciliation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: peri-implant clinical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADOS-R total scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: procedure duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VAS improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate at 180 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median healing time for cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse rate during follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage improvement in worst average daily pruritus numerical rating score (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of word repetition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total OHIP-14 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: early wake time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of N2 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to new episode of HE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of hospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: motor UPDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echogenicity Index (EI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echogenicity Value (EV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enamel Ca/P ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes